Literature DB >> 8104411

Immunosuppressive therapy of autoimmune diseases.

J F Bach1.   

Abstract

Cyclosporin A, corticosteroids and cyclophosphamide show a remarkable efficacy in a large number of autoimmune diseases. However, their effect is dependent on continuous drug administration with potential risks of drug toxicity and over immunosuppression. Results recently obtained in animal models, particularly with anti-CD3 and anti-CD4 monoclonal antibodies, indicate that reestablishment of tolerance to self antigens is a feasible goal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104411     DOI: 10.1016/0167-5699(93)90053-N

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  11 in total

Review 1.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

Review 2.  Current and future therapies for myasthenia gravis.

Authors:  Q Yi; A K Lefvert
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 3.  Superantigens in insulin-dependent diabetes mellitus.

Authors:  P Luppi; M Trucco
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Ilias Frydas; Theoharis C Theoharides
Journal:  Inflamm Res       Date:  2018-06-30       Impact factor: 4.575

5.  Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype.

Authors:  Y Modigliani; V Thomas-Vaslin; A Bandeira; M Coltey; N M Le Douarin; A Coutinho; J Salaün
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

Review 6.  Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

Authors:  A D Dick
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

7.  T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38-kDA autoantigen recognized by T cells from an insulin-dependent diabetic patient.

Authors:  P I Neophytou; B O Roep; S D Arden; E M Muir; G Duinkerken; A Kallan; R R de Vries; J C Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

8.  Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease.

Authors:  A Brás; A P Aguas
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

Review 9.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

10.  Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet's disease patients receiving immunomodulatory treatment.

Authors:  Linlin Cheng; Yang Li; Ziyan Wu; Liubing Li; Chenxi Liu; Jianhua Liu; Jiayu Dai; Wenjie Zheng; Fengchun Zhang; Liujun Tang; Xiaobo Yu; Yongzhe Li
Journal:  BMC Immunol       Date:  2021-02-22       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.